SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs informs about board meeting

26 May 2021 Evaluate

Lyka Labs has informed that as per Regulation 29 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, a Meeting of Board of Directors of the Company is convened on Wednesday, 02 June, 2021, to consider the following businesses: To consider, approve and adopt Standalone Audited Financial Results for the Fourth Quarter and Financial Year ended 31 March, 2021; To consider, approve and adopt Consolidated Audited Financial Results for the Fourth Quarter and Financial Year ended 31 March, 2021. As informed earlier the Trading window is closed from 01 April, 2021 till 48 hours after declaration of Audited Financial Results for the Fourth quarter and Financial year ended 31 March 2021.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

57.52 -2.96 (-4.89%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×